Category: Diagnostic Technologies

Diagnostic Technologies

Austrian Laboratory Network Adopts Digital Pathology Platform to Enable AI-Driven Workflows

The multi-year partnership will implement AISight Dx across five laboratory sites to streamline workflows and support advanced diagnostic capabilities.

Diagnostic Technologies

Foresight Diagnostics Reports Clinical Performance Data for ctDNA Assay in Early-Stage Lung Cancer

Study shows Foresight CLARITY demonstrated 68% pre-operative and 38% post-operative MRD detection rates in stage I lung cancer patients.

Diagnostic Technologies

The Diagnostic Revolution That Could Finally Deliver on the Promise of Precision Medicine—And Why Medical Training Must Catch Up

Despite powerful advances in precision medicine, most doctors remain untrained in these emerging diagnostic tools.

Anatomic Pathology

Agilent Receives FDA Approval for Colorectal Cancer Companion Diagnostic

The MMR IHC Panel pharmDx helps identify patients eligible for immunotherapy treatment with Bristol Myers Squibb's Opdivo alone or in combination with Yervoy.

Digital Pathology

AI Platform Aims to Streamline Clinical Trial Matching at Diagnosis

The new platform automatically identifies clinical trial candidates at diagnosis, leveraging network expected to process 8 million pathology cases annually.

Clinical Chemistry

BioPorto’s Acute Kidney Injury Test Now Available to US Labs Through Roche Partnership

The collaboration marks the first major commercial step to advance adoption of ProNephro AKI across US hospital institutions.

Flow Cytometry

Thermo Fisher Scientific Launches Next-Generation Spectral Flow Cytometry Beads

The beads offer multispecies compatibility and cell-like performance to reduce false positives in flow cytometry analysis.

Hematology & Serology

CoaguSense System Approved in Europe for Self-Monitoring of Oral Anticoagulation Therapy

The Coag-Sense PT/INR Monitoring System gains IVDR approval for home anticoagulation monitoring, marking the company's European market entry.

Immunoassay

Lateral Flow Assays Market Projected to Reach $12.1 Billion by 2030

Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.

Mass Spectrometry

New Nanoparticle System Triples CRISPR Gene-Editing Efficiency

DNA-wrapped lipid nanoparticles show improved cellular uptake and reduced toxicity compared to standard delivery methods used in COVID-19 vaccines.

Microbiology

MALDI Biotyper Sirius and Sirius One Systems Receive Environmental Sustainability Designation

Bruker's MALDI Biotyper sirius and sirius one systems have received the ACT Label from My Green Lab, recognizing responsible design.

Molecular Diagnostics

FDA Clears Tumor Profiling Assay that Analyzes 425 Cancer-Related Genes

The NGS-based test joins CE-IVD and NMPA approvals for global market access.

Point-of-Care

UAE Approves Biomerica’s Home Kidney Test

The test detects early albumin markers in urine within 10 minutes, targeting high-risk diabetes and hypertension patients.

Urinalysis & Toxicology

Upgrading Urine Analyzers to Boost Efficiency and Accuracy

Many clinical laboratories are using outdated urine analyzers, which may affect efficiency and data accuracy.